Value Based Pricing of Pharmaceuticals in the US and UK: Does Centralized Cost Effectiveness Analysis Matter?
Crossref DOI link: https://doi.org/10.1007/s11151-018-9616-1
Published Online: 2018-02-09
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Comanor, William S.
Schweitzer, Stuart O.
Riddle, Jon M.
Schoenberg, Frederic
Text and Data Mining valid from 2018-02-09
Article History
First Online: 9 February 2018